<DOC>
	<DOCNO>NCT00219141</DOCNO>
	<brief_summary>To compare efficacy safety aliskiren combination losartan compare losartan regression increase size leave ventricle overweight patient high blood pressure .</brief_summary>
	<brief_title>Aliskiren Combination With Losartan Compared Losartan Regression Left Ventricular Hypertrophy Overweight Patients With Essential Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patients essential hypertension Patients BMI &gt; 25 kg/m2 Patients LVH ( LVWT â‰¥ 1.3 cm ) confirm ECHO Patients treat ACE ARB within 3 month study entry ( Study Visit 1 ) unable unwilling undergo 3 month washout period . Patients treat ACE ARB combination study entry . Known secondary hypertension etiology ( e.g. , uncorrected renal artery stenosis ) . Other protocol relate inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>